We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$53.2B
AUM Growth
-$223M
Cap. Flow
+$181M
Cap. Flow %
0.34%
Top 10 Hldgs %
28.12%
Holding
4,272
New
228
Increased
1,533
Reduced
1,426
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 13.49%
2 Financials 9.18%
3 Healthcare 8.5%
4 Industrials 7.28%
5 Consumer Staples 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDX icon
3076
Celldex Therapeutics
CLDX
$2.8B
$22K ﹤0.01%
406
DNLI icon
3077
Denali Therapeutics
DNLI
$3.74B
$22K ﹤0.01%
438
-40
-8% -$2.25K
DTF
3078
DTF Tax-Free Income 2028 Term Fund
DTF
$80.7M
$22K ﹤0.01%
1,500
EFR
3079
Eaton Vance Senior Floating-Rate Fund
EFR
$314M
$22K ﹤0.01%
1,500
EGO icon
3080
Eldorado Gold
EGO
$8.48B
$22K ﹤0.01%
2,876
FRSH icon
3081
Freshworks
FRSH
$2.99B
$22K ﹤0.01%
+515
New +$23.1K
GCO icon
3082
Genesco
GCO
$416M
$22K ﹤0.01%
373
-458
-55% -$27.2K
ILF icon
3083
iShares Latin America 40 ETF
ILF
$3.79B
$22K ﹤0.01%
841
JXN icon
3084
Jackson Financial
JXN
$8.44B
$22K ﹤0.01%
+849
New +$23.1K
LTRN icon
3085
Lantern Pharma
LTRN
$35.6M
$22K ﹤0.01%
2,000
MFIN icon
3086
Medallion Financial
MFIN
$226M
$22K ﹤0.01%
2,857
-500
-15% -$4.26K
MIN
3087
Aberdeen Intermediate Income Fund
MIN
$272M
$22K ﹤0.01%
6,000
MOFG
3088
DELISTED
MidWestOne Financial Group
MOFG
$22K ﹤0.01%
724
MRKR icon
3089
Marker Therapeutics
MRKR
$20.3M
$22K ﹤0.01%
1,339
NQP
3090
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$22K ﹤0.01%
1,500
ORMP icon
3091
Oramed Pharmaceuticals
ORMP
$170M
$22K ﹤0.01%
1,000
REVG
3092
DELISTED
REV Group
REVG
$22K ﹤0.01%
1,286
+19
+1% +$303
XT icon
3093
iShares Future Exponential Technologies ETF
XT
$3.78B
$22K ﹤0.01%
350
YALA
3094
Yalla Group
YALA
$809M
$22K ﹤0.01%
+2,870
New +$33.5K
QTTB icon
3095
Q32 Bio
QTTB
$452M
$22K ﹤0.01%
156
+2
+1% +$255
INVX
3096
Innovex International
INVX
$1.85B
$22K ﹤0.01%
870
+805
+1,238% +$21.4K
TPC
3097
Tutor Perini Cor
TPC
$4.51B
$22K ﹤0.01%
1,732
-237
-12% -$3.24K
NKG
3098
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
$22K ﹤0.01%
1,600
TPTX
3099
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$22K ﹤0.01%
328
+14
+4% +$997
OMP
3100
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$22K ﹤0.01%
1,000

Similar funds

US Bancorp's Q3 2021 Portfolio in Review

As of Q3 2021, US Bancorp held 4,272 positions worth $53.2B, down 0.42% from $53.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

US Bancorp's Q3 2021 filing shows 228 new, 1,533 increased, 1,426 reduced and 161 closed positions. Its largest new stake was SentinelOne: 55,534 shares worth $2.97M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $55.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q3 2021 buy was SentinelOne: 55,534 shares worth $2.97M.
  • US Bancorp added most to iShares Core S&P 500 ETF in Q3 2021, an estimated $208M increase.
  • US Bancorp's biggest Q3 2021 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $55.5M.
  • US Bancorp fully exited Maxim Integrated Products in Q3 2021, selling an estimated $18.9M.
  • US Bancorp's ten largest holdings make up 28% of its $53.2B portfolio in Q3 2021.
  • US Bancorp opened 228 new positions and closed 161 in Q3 2021.
  • US Bancorp's portfolio value fell 0.42% quarter-over-quarter to $53.2B.

Based on US Bancorp's 13F filing for Q3 2021, filed 10 Nov 2021.